4-(4-(CHLOROMETHYL)PHENYL)-2-METHYLOXAZOLE, 95.0%, 250mg

8-Bromopyrido[3,4-b]pyrazine, 95.0%, 250mg

(1-(2-((TETRAHYDRO-2H-PYRAN-2-YL)OXY)ETHYL)-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER, 95.0%, 5g

Ethyl 5-amino-1-(2-fluorobenzyl)-1H-pyrazole-3-carboxylate, 98+%, 5g

(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 98%, 25mg

2,3-Dicyanopyrazine>99.0%(GC)100g

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine, 95.0%, 1g

2-Cyano-3-hydroxy pyridine, 98.0%, 5g

3-(chloromethyl)-5-isobutyl-1,2,4-oxadiazole, 95.0%, 5g

Plat ROTILABO® avec fond rainuré, 430 mm, rouge, 1 Pièce

5-Fluoro-4-methyl-2-nitropyridine, 97%, 100mg

Methyl 2-cyano-3-nitrobenzoate, 95.0%, 5g

4-Bromo-7-fluorobenzo[d]thiazol-2-amine, 97%, 1g